BRIEF published on 02/20/2024 at 13:00, 2 years 3 months ago GLG Life Tech Corporation annonce un important accord de transfert d'actifs Développement Durable GLG Life Tech Corporation Transfert D'actifs Réduction De Dette Édulcorants Naturels
PRESS RELEASE published on 11/14/2023 at 13:30, 2 years 6 months ago GLG Life Tech Corporation Reports 2023 Third Quarter Financial Results
PRESS RELEASE published on 08/15/2023 at 01:15, 2 years 9 months ago GLG Life Tech Corporation Reports 2023 Second Quarter Financial Results
PRESS RELEASE published on 06/17/2023 at 00:20, 2 years 11 months ago GLG Life Tech Corporation Announces 2023 AGSM Voting Results
PRESS RELEASE published on 05/15/2023 at 23:15, 3 years ago GLG Life Tech Corporation Reports 2023 First Quarter Financial Results
PRESS RELEASE published on 04/04/2023 at 03:15, 3 years 1 month ago GLG Life Tech Corporation Reports 2022 Annual & Fourth Quarter Financial Results
PRESS RELEASE published on 04/01/2023 at 12:00, 3 years 1 month ago GLG Life Tech Corporation Announces Delay in Filing Year-End Filings
Published on 05/23/2026 at 03:00, 2 minutes ago Battery X Metals Reports Up to ~84 km Estimated Driving Range Increase Across Multiple BYD Electric Vehicles Following Next-Generation Patent-Pending Lithium-Ion Battery Rebalancing Trials, Demonstrating Performance Improvement Across the World’s Larges
Published on 05/23/2026 at 02:25, 37 minutes ago Battery X Metals Announces up to $2 Million Private Placement Financing and Initiative to Strengthen Balance Sheet
Published on 05/23/2026 at 02:25, 37 minutes ago Bolt Metals Completes 402 line-km MobileMT Survey at Northwind Property, Quebec
Published on 05/23/2026 at 01:00, 2 hours 2 minutes ago LIR Life Sciences Announces Initiation of Phase 1 Macromolecule-Enabled Transdermal Delivery Development with Neuland Laboratories
Published on 05/23/2026 at 00:55, 2 hours 7 minutes ago GLG Life Tech Corporation Reports 2026 First Quarter Financial Results
Published on 05/22/2026 at 22:05, 4 hours 57 minutes ago Abivax présente ses résultats financiers du T1 2026 et les données à trois ans de l’étude 108, un essai d’extension ouvert de phase 2a/2b évaluant l’obéfazimod après réduction de dose dans la RCH
Published on 05/22/2026 at 22:05, 4 hours 57 minutes ago Abivax Presents Q1 2026 Financial Results and Reports Three-Year Interim Data from Study 108, a Phase 2a/2b Open-Label Extension Trial of Obefazimod Following Dose De-Escalation in Patients with UC
Published on 05/22/2026 at 19:51, 7 hours 11 minutes ago Turkiye Garanti Bankasi A.S.: Brokerage Houses Warrants Redemption Prices
Published on 05/22/2026 at 18:33, 8 hours 29 minutes ago Update on Coupon payment due on 23 May 2026 and Preparation of the Green Bond Restructuring
Published on 05/22/2026 at 18:30, 8 hours 32 minutes ago Annual General Meeting of Curatis Holding AG approved all proposals of the Board of Directors
Published on 05/22/2026 at 19:35, 7 hours 27 minutes ago PROJET D'EVOLUTION DE SA GOUVERNANCE ET LA NOMINATION D'UN PRESIDENT DU DIRECTOIRE PAR INTERIM
Published on 05/22/2026 at 18:05, 8 hours 56 minutes ago Déclaration hebdomadaire d'opérations effectuées du 18 au 22 mai 2026
Published on 05/22/2026 at 18:05, 8 hours 56 minutes ago Disclosure of transactions in own shares from May 18 to May 22, 2026
Published on 05/22/2026 at 12:52, 14 hours 9 minutes ago Communiqué du Conseil d’administration – Assemblée Générale du 22 mai 2026
Published on 05/22/2026 at 12:52, 14 hours 9 minutes ago Release from the Board of Directors - Shareholders’ Meeting of May 22, 2026
